Ginkgo Bioworks and Agricen Enter Collaboration to Optimize Manufacturing Processes for a Key Agricultural Soil Amendment
DNACollaboration reduces time in fermenting complex bacterial strains, enabling continued focus on next-gen biological crop solutions. BOSTON and PLANO, Texas, Dec. 17, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA, "Ginkgo"), a provider of research and development services and tools for...
Ginkgo Bioworks Selected by PNNL to Deliver a Modular, High‑Throughput Phenotyping Platform for DOE's M2PC
DNABOSTON, Dec. 5, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced it has been awarded by the Environmental Molecular Sciences Laboratory (EMSL) at Pacific Northwest National Laboratory (PNNL) a four-year, up to $47M contract to co-design, build, and integrate a...
Ginkgo Datapoints and Apheris Launch Antibody Developability Consortium
DNA(NYSE:DNA) BOSTON--(BUSINESS WIRE)--Ginkgo Bioworks announced a series of new initiatives to accelerate the application of artificial intelligence in biologics drug discovery.
Ginkgo Bioworks Issues Notice of Settlement of Shareholder Derivative Actions
DNA(NYSE:DNA) BOSTON, Aug. 29, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today released the following notice: UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA OAKLAND DIVISION WEINING HU, derivatively on behalf of GINKGO BIOWORKS HOLDINGS, INC., a Delaware corporation, Plaintiff, vs....
Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Partner to Deploy AI-driven Lab-in-the-loop Workflows Across the Biopharma Industry
DNABOSTON, Aug. 20, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that its Datapoints offering has entered into a new strategic partnership with Inductive Bio and Tangible Scientific to make...
Ginkgo Automation Appoints Brian O'Sullivan as Head of Commercial to Accelerate External Growth
DNASeasoned life‑science executive to spearhead global go‑to‑market strategy as Ginkgo Automation scales external sales across biopharma, techbio, and new science‑driven markets while continuing to support internal programs. BOSTON, Aug. 12, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA),...
Ginkgo Bioworks Reports Second Quarter 2025 Financial Results
DNAGinkgo provides an update on its restructuring, including achievement of its expanded $250 million cost savings targets BOSTON, Aug. 7, 2025 /PRNewswire/ -- Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity,...
Ginkgo Bioworks Appoints Steven Coen As CFO
DNATwist Bioscience And Ginkgo Bioworks Announces Revision In Its Three-Year $15M Collaboration Including Ginkgo Receiving Preferential Pricing With No Required Minimum Purchase Volume
DNAGinkgo Bioworks Holdings Updates FY2025 Sales Guidance from $160.00M-$180.00M to $167.00M-$187.00M vs $202.01M Est
DNAGinkgo Bioworks Holdings Q1 EPS $(1.68) Beats $(1.69) Estimate, Sales $48M Beat $43.12M Estimate
DNAGinkgo Bioworks Holdings Sees FY2025 Sales $160.000M-$180.000M vs $203.80M Est
DNAGinkgo Bioworks Holdings Q4 EPS $(2.00) Misses $(1.77) Estimate, Sales $43.85M Miss $44.46M Estimate
DNAGinkgo Bioworks Enters Into A Collaboration With HaDEA Under EU4Health Programme For Up To €24M Through Joint Tender
DNA'Massive Foundation Model For Biomolecular Sciences Now Available Via NVIDIA BioNeMo; Evo 2, a powerful new AI model built using NVIDIA DGX Cloud on AWS, provides insights into DNA, RNA and proteins across diverse species' - Nvidia
DNAGinkgo Bioworks Partners With Universal Cells To Advance Next-Generation iPSC-Derived Cell Therapies For Solid Tumors
DNAGinkgo Bioworks Shares Resume Trade Following Circuit Breaker Halt, Stock Now Down 5.05%
DNAGinkgo Bioworks Shares Halted On Circuit Breaker
DNA